作者: Zhaozhong J. Jia , Wolin Huang , Yonghong Song , Qing Xu , Anjali Pandey
DOI:
关键词:
摘要: The present invention is directed to compounds of formula (I) and tautomers thereof or pharmaceutically acceptable salts, esters, prodrugs which arc inhibitor Syk kinase. also intermediates used in making such compounds, the preparation a compound, pharmaceutical compositions containing methods inhibition kinase activity, platelet aggregation, prevent treat number conditions mediated at least part by as undesired thrombosis Non Hodgkin's Lymphoma.